Evidence map›Paper›PMID 41476122›Full record

ArticleNPJ digital medicine2025

A clinically validated 3D deep learning approach for quantifying vascular invasion in pancreatic cancer.

Yajiao Zhang, Haoran Zhang, Yanzhao Yang, Chao Wu, Lei Zhang, Wei Xia, Xue Wang, Xiaohuan Zhang, Lixiu Cao, Manju Liu and 4 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yajiao Zhang *Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Haoran Zhang *Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yanzhao Yang *Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chao WuDepartment of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lei ZhangDepartment of Radiology, Wuxi No.2 People's Hospital (Jiangnan University Medical Center), Wuxi, China.
Wei XiaDepartment of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xue WangDepartment of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xiaohuan ZhangDepartment of Radiology, Wuxi No.2 People's Hospital (Jiangnan University Medical Center), Wuxi, China.
Lixiu CaoDepartment of Nuclear Medicine, Tangshan People's Hospital, Tangshan, Hebei Province, China.
Manju LiuMedical Physics Graduate Program, Duke Kunshan University, Kunshan, Jiangsu Province, China.
Jing ZhangDepartment of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fuhua YanDepartment of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. yfh11655@rjh.com.cn.
Baiyong ShenDepartment of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. shenby@shsmu.edu.cn.
Ning WenDepartment of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. wn12479@rjh.com.cn.

Funding

National Center for Translational Medicine (Shanghai) NRCTM(SH)-2025-11National Key Research and Development Program of China 2022YFC2409501National Natural Science Foundation of China 82472065Shanghai Explorer Program 24TS1414900Shanghai Pujiang Program 2023PJD055
6 · The paper itself

Abstract

Vascular invasion assessment is critical for surgical planning in pancreatic ductal adenocarcinoma (PDAC). Current CT-based assessments often rely on radiologists' subjective 2D interpretations, which may not capture the continuous, three-dimensional tumor-vessel interactions and multiple vessel involvement, both essential for accurate preoperative evaluation. PAN-VIQ (Pancreatic Vascular Invasion Quantifier) is an automated deep learning framework to quantify tumor-vessel interactions from contrast-enhanced CT scans. It enables segmentation of pancreatic tumors and five critical vessels: celiac artery (CA), common hepatic artery (CHA), superior mesenteric artery (SMA), superior mesenteric vein (SMV), and portal vein (PV), quantifying vascular involvement through 3D encasement angles. PAN-VIQ was trained and internally validated on 2130 cases, and subsequently prospectively tested in 202 patients. External validation showed accuracies exceeding 90%. In prospective evaluation, the model outperformed junior radiologists and matched senior radiologists in accuracy and recall. These results underscore potential of PAN-VIQ to standardize vascular invasion assessment and reduce interobserver variability.

Identifiers

PMID41476122
PMCPMC12848109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.